Atif Awan
Overview
Explore the profile of Atif Awan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wildes D, OReilly D, Brennan E, Drew R, Awan A, Boyle M
BMJ Paediatr Open
. 2025 Mar;
9(1).
PMID: 40044496
Introduction: Neonatal sepsis remains a leading cause of morbidity and mortality across all healthcare systems. Acute kidney injury (AKI) is common in neonates and is associated with poor clinical outcomes....
2.
Wildes D, Mullaly R, Costigan C, Awan A, El-Khuffash A, Boyle M
Acta Paediatr
. 2025 Jan;
PMID: 39887836
Aim: This study hypothesised that infants with a haemodynamically significant patent ductus arteriosus (hsPDA) as defined by a validated score have a higher incidence of acute kidney injury (AKI). Methods:...
3.
Elhassan E, ODonoghue D, Heneghan S, Teltsh O, Sarihan S, Osman S, et al.
J Nephrol
. 2025 Jan;
PMID: 39881088
Background: Autosomal Dominant Polycystic Kidney Disease (ADPKD) represents the most common monogenic cause of kidney failure. While identifying genetic variants predicts disease progression, characterization of recently described ADPKD-like variants is...
4.
Prytula A, Reynders D, Goetghebeur E, Krupka K, Bacchetta J, Kanzelmeyer N, et al.
Pediatr Nephrol
. 2025 Jan;
PMID: 39865159
Background: We investigated factors associated with post-transplant growth in pediatric kidney transplant (KTx) recipients with a focus on plasma bicarbonate (HCO3) and estimated the effect of alkali treatment on growth....
5.
Somanadhan S, McAneney H, Awan A, McNulty S, Sweeney A, Buckle N, et al.
J Pediatr Nurs
. 2025 Jan;
81():31-42.
PMID: 39837019
Purpose: Rare diseases are individually uncommon yet collectively prevalent. They affect over 300,000 people in Ireland, with 50-70 % impacting children. This study explores the supportive care needs of parents...
6.
Ehrich J, Tasic V, Edvardsson V, Preka E, Prikhodina L, Stefanidis C, et al.
Front Pediatr
. 2025 Jan;
12:1458003.
PMID: 39759883
Background: There is a lack of information on the current healthcare systems for children with kidney diseases across Europe. The aim of this study was to explore the different national...
7.
Baghai Arassi M, Feisst M, Krupka K, Awan A, Benetti E, Duzova A, et al.
Kidney Int Rep
. 2024 Nov;
9(11):3265-3277.
PMID: 39534206
Introduction: Data on age-related differences in rejection rates, infectious episodes, and tacrolimus exposure in pediatric kidney transplant recipients (pKTRs) on a tacrolimus-based immunosuppressive regimen are scarce. Methods: We performed a...
8.
Wildes D, Awan A, Sweeney C
Pediatr Nephrol
. 2024 Oct;
40(3):875.
PMID: 39466388
No abstract available.
9.
Fichtner A, Schmidt J, Susal C, Carraro A, Oh J, Zirngibl M, et al.
Pediatr Nephrol
. 2024 Oct;
40(3):835-848.
PMID: 39392493
Background: In kidney transplant recipients (KTR), BK polyomavirus-associated nephropathy (BKPyVAN) is a major cause of graft loss. To facilitate the clearance of BKPyV-DNAemia, reduction of immunosuppression is currently the treatment...
10.
Kelly E, Awan A, Sweeney C, Wildes D, De Gascun C, Hassan J, et al.
Pediatr Transplant
. 2024 Sep;
28(7):e14857.
PMID: 39318279
Background: Long-term renal function and survival after kidney transplantation rely on appropriate immunosuppressive treatment to prevent the risk of rejection. New biomarkers are needed to accurately assess the degree of...